Tag: Diabetes
Abbott seeks to go ‘above the bias’
March 28, 2025Theresa Flaherty, Managing Editor
ALAMEDA, Calif. – Nearly 70% of people with diabetes believe there is stigma associated with their condition, according to a survey from Abbott, and that can stand in the way of care, says Dr. Mahmood Kazemi.
“Misconceptions and stereotypes about diabetes can prevent some people from getting care,” said Kazemi, divisional vice president, medical/clinical affairs and chief medical officer, Abbott Diabetes Care. “It’s disheartening. What is promising, though,...
FDA issues warning to Dexcom
March 27, 2025HME News Staff
SAN DIEGO – Dexcom has received a warning letter from the U.S. Food and Drug Administration regarding “non-conformities” in manufacturing and quality processes after inspections of its facilities in Sad Diego and Mesa, Ariz. In a form 8-K filed with the U.S. Securities and Exchange Commission, the company said it takes the matters identified in the warning letter seriously, has already submitted several responses to Form 483 and is in the process of preparing a written response...
DMEs improve adherence, lower costs & reduce utilization, study finds
March 25, 2025HME News Staff
DALLAS – There are significant advantages for patients receiving continuous glucose monitors through DME providers compared to pharmacies, including higher adherence rates, according to a new study published in Clinical Diabetes, a peer-reviewed journal of the American Diabetes Association.
The study, supported by CCS, demonstrates that efforts to expand access to CGMs by adding pharmacy as a new channel for distribution — alongside the established DME provider channel —...
‘Now is the time to push for greater investment in CGM tech,’ report finds
March 24, 2025HME News Staff
EDINBURGH, Scotland, and SAN DIEGO – Tech, not medicine, is the future of care for Type 2 diabetes patients, according to a new report from Dexcom.
Fifty-two percent of health care professionals ranked access to continuous glucose monitors and education as having the potential to positively help people with Type 2 manage their condition in the next 10 years compared with 30% who cited better or more effective medications.
“With policymakers increasingly focused on digital...
DME providers can help physicians manage diabetes population, study finds
March 21, 2025Theresa Flaherty, Managing Editor
DALLAS – The No. 1 reason physicians cite for not prescribing a continuous glucose monitor is its complexity, a roadblock that DME providers can help clear, according to a new study from CCS.
That complexity, along with a surge in the number of diabetes patients, leaves primary care physicians and endocrinologists feeling overwhelmed and not able to keep up-to-date on technology, and, ultimately, struggling to offer enough health coaching and education to their patients. That creates...
Sequel Med Tech collaborates with Abbott
March 19, 2025HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...
Strive Medical builds out diabetes biz
March 5, 2025HME News Staff
IRVING, Texas – Strive Medical, a portfolio company of NMS Capital, has acquired Charles Pharmacy & Surgical, a pharmacy and provider of diabetes supplies since 1968.
This strategic acquisition represents a major milestone in Strive Medical's continuous growth and dedication to delivering top-quality medical supplies and services to patients throughout the United States, the company says.
"We are thrilled to welcome Charles Pharmacy into the Strive Medical community,"...
In brief: Owens & Minor explores P&HS sale, Grassley challenges UHC, CCS details burnout
February 28, 2025HME News Staff
RICHMOND, Va.– Owens & Minor is looking to sell off its Products & Healthcare Services business, while it remains “bullish” on its Patient Direct business.
The company made the announcement today, as part of its fourth quarter and full-year 2024 earnings results.
“Our commitment to directing capital toward the higher growth and higher margin Patient Direct segment has been increasingly evident in recent years and is consistent with our strategy,” said...
AdaptHealth: Diabetes course correct shows ‘promising signs’
February 26, 2025Theresa Flaherty, Managing Editor
PLYMOUTH MEETING, Pa. – After consecutive declining quarters in Diabetes Health, AdaptHealth has remodeled its diabetes outreach program and integrated diabetes resupply into sleep resupply and adopted that segment's best practices, says CEO Suzanne Foster.
A diagnostic review highlighted several reasons for Diabetes Health’s underperformance, she told analysts on a recent call to discuss the company’s fourth quarter and full year 2024 financial results.
“Notwithstanding...
CCS study: Physicians ‘overwhelmed’ by soaring diabetes numbers
February 26, 2025HME News Staff
DALLAS – The vast majority of physicians caring for people with diabetes say they are overwhelmed, according to a new study from CCS, a provider of clinical solutions and home medical supplies for those living with chronic conditions.
Eighty-five percent of endocrinologists and 58% of PCPs feel overwhelmed by the number of patients with diabetes, demonstrating that many are not in a position to properly support the ongoing education and coaching needs of people living with diabetes,...